retatrutides Retatrutide Promises Big Weight Loss, but Safety Remains a Question Triple G 20 mg (Retatrutyd)

It is known as a GIP/glucagon-like peptide-1 receptor (GLP-1) agonist and has the same active ingredient as Mounjaro (tirzepatide)

Ania Jastreboff, MD, PhD, Endocrinologist and Obesity Medicine Specialist PLEASE NOTE: Retatrutide is supplied as a high-purity lyophilized powder intended strictly for laboratory studies and preclinical research use only, and it is not approved for human or veterinary use

Research suggests that glutathione may offer more advantages when given intravenously instead of by pill

In contrast, those using Tirzepatide achieved higher monthly weight loss percentages: approximately 5.9% after 3 months, 10.1% after 6 months, and 15.3% after 12 months, surpassing the weight loss observed with semaglutide